Astrotech Reports First Quarter of Fiscal Year 2018 Financial Results
Austin, TX - November 8, 2017 -
Astrotech Corporation (NASDAQ: ASTC) reported its financial results for the first quarter of fiscal year 2018 ended September 30, 2017.
“In the first quarter, our subsidiary 1st Detect achieved a significant milestone toward the deployment of explosives trace detector systems with the Transportation Security Administration (TSA),” said Thomas B. Pickens III, Chairman and CEO of Astrotech Corporation. “In September, we announced that we entered a Cooperative Research and Development Agreement (CRADA) with the Department of Homeland Security (DHS) Science and Technology Directorate (S&T) Transportation Security Laboratory (TSL) for the development, testing, and evaluation of our TRACER 1000 MS-ETD system. Using TSL’s credible, unbiased and objective Developmental Test and Evaluation (DT&E) process, TSL and 1st Detect will examine ways to improve trace detection capabilities in support of transportation security.
“1st Detect’s healthcare product for breath analysis, the BreathDetect 1000, continues to make progress in pre-clinical trials with cystic fibrosis patients at UT Health San Antonio (UTHSA). Our partnership with UTHSA is initially focusing on identifying hospital-acquired pneumonia (HAP), of which there are over 150,000 cases reported annually. By enabling detection of HAP and reducing the wait time for a proper diagnosis from several days to within minutes, the BreathDetect 1000 can significantly enhance the physician’s ability to administer optimal antibiotics–reducing the liability exposure for hospitals while saving lives.
“In addition, Astral Images was selected by a post-production house for the digital conversion of a feature-length film that included defect correction using our Astral Color ICE proprietary technology. Astral was chosen for its ability to detect defects in automation while reducing costs and turnaround time. Astral continues to be positioned to lead the conversion of digital film as global adoption of 4K HDR televisions ramps up and demand for 4K HDR content and services grows,” Mr. Pickens concluded.
First Quarter Fiscal Year 2018 Financial Highlights
Revenue, costs of goods sold, SG&A, and R&D are expected to continue to fluctuate based on the timing of projects.
1st Detect’s income from research-based, fixed-price, government-related subcontract agreements ended during the last quarter of fiscal 2017. Therefore, there was no revenue or gross profit generated in the first quarter of fiscal 2018, compared to $1.0 million and $275 thousand, respectively, in the first quarter of fiscal 2017. Cash and investments at September 30, 2017 were $11.6 million, and there was no debt.
Astrotech Corporation (NASDAQ: ASTC) is an innovative science and technology company that invents, acquires, and commercializes technological innovations sourced from research institutions, laboratories, universities, and internally, and then funds, manages, and builds proprietary, scalable start-up companies for profitable divestiture to market leaders to maximize shareholder value. Sourced from Oak Ridge Laboratory’s chemical analyzer research, 1st Detect develops, manufactures, and sells chemical analyzers for use in the security, defense, healthcare, food and beverage, and environmental markets. Sourced from decades of image research from the laboratories of IBM and Kodak, Astral Images sells film-to-digital image enhancement, defect removal and color correction software, and post processing services providing economically feasible conversion of television and feature 35mm and 16mm films to the new 4K ultra-high definition (UHD), high-dynamic range (HDR) format necessary for the new generation of digital distribution. Sourced from NASA’s extensive microgravity research, Astrogenetix is applying a fast-track, on-orbit discovery platform using the International Space Station to develop vaccines and other therapeutics. Demonstrating its entrepreneurial strategy, Astrotech management sold its state-of-the-art satellite servicing operations to Lockheed Martin in August 2014. Astrotech has operations throughout Texas and is headquartered in Austin.
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, whether we can successfully develop our proprietary technologies and whether the market will accept our products and services, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. The Company assumes no obligation to update these forward-looking statements.
Chief Financial Officer
Cathy Mattison and Kirsten Chapman
LHA Investor Relations